Quick Takeaways
- Darwin Global Management, Ltd. has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $305,952,424.
- Recent insider filing activity is available below.
- Info
- Portfolio
- Significant Ownership
- Insider Ownership
Insider Trading & Ownership of Darwin Global Management, Ltd.
- Location
- St. Helier, Jersey
- Summary
- The estimated value of insider holdings of Darwin Global Management, Ltd. is at least $305,952,424 dollars as of 28 Jun 2023. Darwin Global Management, Ltd. is the 10%+ Owner of Ambrx Biopharma Inc. and owns shares of Ambrx Biopharma Cayman, Inc. stock worth about $305.95M.
- Signature
- Darwin Global Management, Ltd. By: /s/ John Legge, Director and Chief Financial Officer
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Darwin Global Management, Ltd. and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Ambrx Biopharma Inc. ($305,952,424).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Darwin Global Management, Ltd.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| AMAM | Ambrx Biopharma Inc. | 10%+ Owner | $305,952,424 | 27 Jun 2023 |
Insider Transactions Reported by Darwin Global Management, Ltd.:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.